SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

TARS

Tarsus Pharmaceuticals Inc.
NASDAQHealth Care

Latest close: 68.07 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 13, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 15, 2026Reported sale · Form 4WILLIAM J LINK PHD · $914.5KOpen the filing ↗
  3. Sep 15, 2026Reported sale · Form 4WILLIAM J LINK PHD · $60.0KOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record64819 flagged findings
Reported transactions (Form 4)80since Mar 15, 2026 · and 7 other holdings
Corporate events (8-K)29since Nov 20, 2020

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-06capital return (buybacks/dividends)recentOpen filing ↗
    “…requirements associated with such operating plans. If we raise additional funds by issuing equity securities, our stockholders may…”
  • 2026-05-06regulatory investigationrecentOpen filing ↗
    “…Rebate Program, whether due to a misstated FCP or otherwise, we will be required to refund the difference to the government. Failure…”
  • 2026-02-23share offering or dilution eventrecentOpen filing ↗
    “…Equity Shares Amount Balance as of December 31, 2022 26,727,458 $ 5 $ 301,732 $ ( 74 ) $ ( 108,763 ) $ 192,900 Net loss — — —…”
    +1 more passage from the same document
    • “…under the 2024 Shelf Registration Statement of 2,812,500 shares of the Company’s common stock, par value $ 0.0001 per share, and,…”
  • 2026-02-23capital return (buybacks/dividends)recentOpen filing ↗
    “…requirements associated with such operating plans. If we raise additional funds by issuing equity securities, our stockholders may…”
  • 2026-02-23regulatory investigationrecentOpen filing ↗
    “…Rebate Program, whether due to a misstated FCP or otherwise, we will be required to refund the difference to the government. Failure…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 648)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 13, 268-K/A ↗Current report · Financial statements and exhibits · amendment new
  • Oct 13, 26S-3ASR ↗Securities offering new
  • Oct 13, 26S-3ASR ↗Securities offering new
  • Insider transaction · 3 Form 4 filingsshow all 3hide
  • Sep 15, 26Form 144 ↗Notice of proposed sale
  • Sep 10, 268-K ↗Current report · Completed an acquisition or disposal
  • Insider transaction · 3 Form 4 filingsshow all 3hide
  • Notice of proposed sale · 4 Form 144 filingsshow all 4hide
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Notice of proposed sale · 8 Form 144 filingsshow all 8hide

648 filings on record, the oldest from Sep 4, 20.

Listing the 25 most recent filings of the 648 on record.

8-Ks, explained

Structure18Governance11
  • Sep 10, 26StructureCompleted an acquisition or disposal+2 more in the same filing8-K 2.01 ↗
  • Aug 6, 26StructureSold unregistered shares+3 more in the same filing8-K 3.02 ↗
  • Aug 6, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Jul 13, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jul 8, 26StructureSold unregistered shares+3 more in the same filing8-K 3.02 ↗
  • Feb 18, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Mar 13, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jan 17, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Dec 19, 24StructureEntered a material agreement8-K 1.01 ↗
  • Nov 5, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Apr 23, 24StructureTook on a new financial obligation+3 more in the same filing8-K 2.03 ↗
  • Mar 1, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗

12 older filings not shown

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Deep Track Capital, LP8.5%Mar 31, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • RTW Investments, LP8.1%Jun 30, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • BlackRock, Inc.7.4%Mar 31, 25SCHEDULE 13G/A ↗
  • JANUS HENDERSON GROUP Ltd.6.5%Jun 30, 26SCHEDULE 13G/A ↗1 earlier filing
  • Cowen Financial Products LLC4.9%Dec 31, 24SCHEDULE 13G/A ↗
show 4 more holdershide

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Sep 15, WILLIAM J LINK filed notice of intent to sell up to $980K. That is about 0.03% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $980K across 3 trades on Sep 15, per their Form 4. That is 100% of the shares announced so far, and the window is still open.

View notice (Form 144) ↗+9 more recent notices · 5 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Sep 15, 26Sell$915KWILLIAM J LINK PHD↗
  • Sep 15, 26Sell$60KWILLIAM J LINK PHD↗
  • Sep 15, 26Sell$5KWILLIAM J LINK PHD↗
  • Sep 4, 26Sell$388KSeshadri NeervannanChief Operating Officer↗
  • Sep 4, 26Sell$641KBobak R. AzamianPresident/CEO and Board Chair↗
  • Sep 4, 26Sell$265KBobak R. AzamianPresident/CEO and Board Chair↗
  • Sep 4, 26Sell$458KElizabeth Yeu LinChief Medical Officer↗
  • Sep 4, 26Sell$485KElizabeth Yeu LinChief Medical Officer↗
  • Sep 4, 26Sell$135KElizabeth Yeu LinChief Medical Officer↗
  • Sep 4, 26Sell$143KElizabeth Yeu LinChief Medical Officer↗
  • Sep 2, 26Sell$801KBobak R. AzamianPresident/CEO and Board Chair↗
  • Sep 2, 26Sell$431KElizabeth Yeu LinChief Medical Officer↗

There are 17 more transactions in this stretch.

Stock compensation, tax and giftsshow the 11 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 15, 26Compensationamount n/aDAVID E I PYOTT↗
  • Sep 15, 26Compensationamount n/aWENDY L YARNO↗
  • Sep 15, 26Compensationamount n/aWILLIAM J LINK PHD↗
  • Jun 15, 26Compensationamount n/aJeffrey S FarrowSee Remarks↗
  • Jun 12, 26Compensationamount n/aWENDY L YARNO↗
  • Jun 12, 26Compensationamount n/aWILLIAM J LINK PHD↗
  • Jun 12, 26Compensationamount n/aBHASKAR CHAUDHURI↗
  • Jun 12, 26Compensationamount n/aScott W Morrison↗
  • Jun 12, 26Compensationamount n/aAndrew D. Goldberg↗
  • Jun 12, 26Compensationamount n/aKatherine Goodrich↗
  • Apr 24, 26Compensationamount n/aDAVID E I PYOTT↗

The full record holds 263 transactions and goes back to Jan 6, 23.

Its sector and its market

Tarsus Pharmaceuticals Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Tarsus Pharmaceuticals Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Tarsus Pharmaceuticals Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
648 documents on file, from Sep 4, 2020 to Oct 13, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.